Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 146 Head and Neck Neoplasms 80 Squamous Cell Carcinoma of Head and Neck 69 Rectal Neoplasms 46 Colonic Neoplasms 42 Carcinoma, Non-Small-Cell Lung 39 Neoplasm Metastasis 35 Neoplasms 25 Carcinoma, Squamous Cell 20 Pancreatic Neoplasms 17 Lung Neoplasms 16 Esophageal Neoplasms 15 Stomach Neoplasms 12 Recurrence 11 Laryngeal Neoplasms 11 Mouth Neoplasms 10 Oropharyngeal Neoplasms 8 Esophageal Squamous Cell Carcinoma 8 Breast Neoplasms 8 Adenocarcinoma Of Esophagus 8 Tongue Neoplasms 7 Uterine Cervical Neoplasms 6 Nasopharyngeal Carcinoma 6 Laryngeal Diseases 6 Hypopharyngeal Neoplasms 6 Colorectal Cancer Metastatic 6 Carcinoma 6 Adenocarcinoma of Lung 6 Salivary Gland Neoplasms 5 Cholangiocarcinoma 4

Interventions

Docetaxel 5 S 1 (combination) 2 Carboplatin 2 zimberelimab 1 surufatinib 1 quemliclustat 1 pemigatinib 1 nimotuzumab 1 lorlatinib 1 cemiplimab 1 Vinorelbine 1 Pemetrexed 1 Paclitaxel 1 Gene Expression Profiling 1 Gemcitabine 1 Erlotinib Hydrochloride 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Non-Small Cell Lung Cancer × Cetuximab × Clear all

NCT00330746 2012-05-18

CALC-1

National Cancer Institute, Naples

Phase 2 Completed

Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡